Xiamen Maili Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Xiamen Maili Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 11 (Environmental Control) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GRACEME. The owner is based in Xiamen, Fujian.
No. 2-3-1, Xiaweishe Middle Road
Dongyao Village, Haicang District
Xiamen, Fujian 361027 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiamen Maili Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does Xiamen Maili Technology Co., Ltd. have?
Xiamen Maili Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Xiamen Maili Technology Co., Ltd. file in?
Xiamen Maili Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 11 (Environmental Control). Class 35 covers advertising; business management; business administration; office functions.
What are Xiamen Maili Technology Co., Ltd.'s most well-known trademarks?
Xiamen Maili Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as GRACEME. These are among 1 currently registered trademark in the portfolio.
What is Xiamen Maili Technology Co., Ltd.'s trademark registration success rate?
Xiamen Maili Technology Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.